Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density L Van Wesenbeeck, E Cleiren, J Gram, RK Beals, O Bénichou, ... The American Journal of Human Genetics 72 (3), 763-771, 2003 | 651 | 2003 |
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene E Cleiren, O Bénichou, E Van Hul, J Gram, J Bollerslev, FR Singer, ... Human molecular genetics 10 (25), 2861-2867, 2001 | 445 | 2001 |
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial C Becker, SR Lord, SA Studenski, SJ Warden, RA Fielding, CP Recknor, ... The lancet Diabetes & endocrinology 3 (12), 948-957, 2015 | 386 | 2015 |
Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients OD Benichou, JD Laredo, MC De Vernejoul Bone 26 (1), 87-93, 2000 | 293 | 2000 |
A phase II randomized study of subcutaneous ixekizumab, an anti–interleukin‐17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an … MC Genovese, M Greenwald, CS Cho, A Berman, L Jin, GS Cameron, ... Arthritis & rheumatology 66 (7), 1693-1704, 2014 | 219 | 2014 |
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: 52-week results from a phase III study (SPIRIT-P1) D van der Heijde, DD Gladman, M Kishimoto, M Okada, SS Rathmann, ... The Journal of rheumatology 45 (3), 367-377, 2018 | 126 | 2018 |
Rationale for strengthening muscle to prevent falls and fractures: a review of the evidence O Benichou, SR Lord Calcified tissue international 98 (6), 531-545, 2016 | 119 | 2016 |
A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate MC Genovese, E Lee, J Satterwhite, M Veenhuizen, D Disch, PY Berclaz, ... Annals of the rheumatic diseases 72 (9), 1453-1460, 2013 | 111 | 2013 |
Tibial coverage, meniscus position, size and damage in knees discordant for joint space narrowing–data from the Osteoarthritis Initiative K Blöcker, A Guermazi, W Wirth, O Benichou, CK Kwoh, DJ Hunter, ... Osteoarthritis and cartilage 21 (3), 419-427, 2013 | 107 | 2013 |
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21 W Van Hul, J Bollerslev, J Gram, E Van Hul, W Wuyts, O Benichou, ... The American Journal of Human Genetics 61 (2), 363-369, 1997 | 89 | 1997 |
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors MC Genovese, RM Fleischmann, M Greenwald, J Satterwhite, ... Annals of the rheumatic diseases 72 (9), 1461-1468, 2013 | 85 | 2013 |
Sensitivity to change of cartilage morphometry using coronal FLASH, sagittal DESS, and coronal MPR DESS protocols–comparative data from the Osteoarthritis Initiative (OAI) W Wirth, M Nevitt, MPH Le Graverand, O Benichou, D Dreher, RY Davies, ... Osteoarthritis and Cartilage 18 (4), 547-554, 2010 | 85 | 2010 |
MRI-based extended ordered values more efficiently differentiate cartilage loss in knees with and without joint space narrowing than region-specific approaches using MRI or … W Wirth, R Buck, M Nevitt, MPH Le Graverand, O Benichou, D Dreher, ... Osteoarthritis and Cartilage 19 (6), 689-699, 2011 | 82 | 2011 |
Femorotibial subchondral bone area and regional cartilage thickness: A cross‐sectional description in healthy reference cases and various radiographic stages of osteoarthritis … RB Frobell, MC Nevitt, M Hudelmaier, W Wirth, BT Wyman, O Benichou, ... Arthritis care & research 62 (11), 1612-1623, 2010 | 80 | 2010 |
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13. 3 O Bénichou, E Cleiren, J Gram, J Bollerslev, MC de Vernejoul, W Van Hul The American Journal of Human Genetics 69 (3), 647-654, 2001 | 80 | 2001 |
Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force M Cesari, R Fielding, O Bénichou, R Bernabei, S Bhasin, JM Guralnik, ... The Journal of frailty & aging 4 (3), 114, 2015 | 79 | 2015 |
A Phase 2 Randomized Study Investigating the Efficacy and Safety of Myostatin Antibody LY2495655 versus Placebo in Patients Undergoing Elective Total Hip Arthroplasty. L Woodhouse, R Gandhi, SJ Warden, S Poiraudeau, SL Myers, ... The Journal of frailty & aging 5 (1), 62-70, 2016 | 77 | 2016 |
Human osteopetrosis and other sclerosing disorders: recent genetic developments MC Vernejoul, O Benichou Calcified Tissue International 69 (1), 1, 2001 | 73 | 2001 |
Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis? B Cortet, O Bénichou Joint Bone Spine 73 (5), e1-e7, 2006 | 72 | 2006 |
Rates of change and sensitivity to change in cartilage morphology in healthy knees and in knees with mild, moderate, and end‐stage radiographic osteoarthritis: Results from 831 … F Eckstein, M Nevitt, A Gimona, K Picha, JH Lee, RY Davies, D Dreher, ... Arthritis care & research 63 (3), 311-319, 2011 | 70 | 2011 |